As with all medications, GLP-1 receptor agonists carry potential adverse effects, most commonly gastrointestinal symptoms such as nausea, vomiting, diarrhoea, and constipation
Appetite suppression often occurs before measurable weight loss appears on the scale
Are side effects manageable
However, compounding pharmacies are subject to FDA and state regulation and compounded semaglutide offers a patient-specific formulation, is currently more widely available, and offers greater customization of dosing titration protocols on a per patient basis
Patients benefit from rapid relief in mood, increased energy levels, and enhanced neurotransmitter function, with minimal side effects compared to other approaches
In a study of almost 40,000 people taking either weight loss medications, the majority of people either maintained or continued to lose weight after a year of stopping their medication